HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrence of hemolytic-uremic syndrome following live related renal transplantation.

Abstract
There is a significant risk of disease recurrence in patients with diarrhea-negative hemolyticuremic syndrome undergoing renal transplantation. Considering the low frequency of hemolyticuremic syndrome among adults with end-stage renal disease, only a few reports are available on the outcome of these patients after renal transplantation. It has been suggested, though not proven, that living related transplant recipients are at increased risk of recurrence of hemolyticuremic syndrome. We report a 23-year-old woman with end-stage renal disease, owing to postpartum hemolyticuremic syndrome and the recurrence of the disease following live related renal transplant. Investigators believe that some cases of atypical hemolytic-uremic syndrome are familial and related donors may have a genetic susceptibility to develop hemolytic-uremic syndrome. In addition, recurrence of hemolytic-uremic syndrome in the allograft is associated with a very poor prognosis. Therefore, at present, many clinicians are reluctant to recommend live related transplantation in any forms of diarrhea-negative hemolytic-uremic syndrome.
AuthorsDiana Taheri, Shiva Seyrafian, Ardeshir Talebi, Kim Solez
JournalArchives of Iranian medicine (Arch Iran Med) Vol. 9 Issue 2 Pg. 170-2 (Apr 2006) ISSN: 1029-2977 [Print] Iran
PMID16649365 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Family
  • Female
  • Genetic Predisposition to Disease
  • Hemolytic-Uremic Syndrome (genetics, pathology)
  • Humans
  • Kidney Failure, Chronic (surgery)
  • Kidney Transplantation
  • Living Donors
  • Recurrence
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: